Ownership history in ORBIMED ADVISORS LLC · 6 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in MBX BIOSCIENCES INC (MBX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 3,935,203 | -67,684 | -1.7% | 2.53% | $124.1M | $31.54 |
| 2025 Q3 | UNCHANGED | 4,002,887 | — | 0% | 1.65% | $70.1M | $17.50 |
| 2025 Q2 | UNCHANGED | 4,002,887 | — | 0% | 1.14% | $45.7M | $11.41 |
| 2025 Q1 | ADDED | 4,002,887 | +190,672 | +5.0% | 0.70% | $29.5M | $7.38 |
| 2024 Q4 | UNCHANGED | 3,812,215 | — | 0% | 1.45% | $70.3M | $18.43 |
| 2024 Q3 | INITIATED | 3,812,215 | — | — | 1.80% | $99.0M | $25.98 |
As of 2025 Q4 — sorted by position size